BioSpace News Archive

Drug Development

Ablynx Reports Additional Clinically Important Benefits of Caplacizumab From Its Phase III Hercules Study in Acquired TTP

These new data relate to additional pre-specified secondary endpoints and demonstrate that treatment with caplacizumab resulted in a clinically meaningful reduction in the use of PEX and length of stay in the ICU and the hospital.

December 12, 2017

·

10 min read

Biotech Bay

Corium to Join NASDAQ Biotechnology Index

This will become effective prior to market open on Monday, December 18, 2017.

December 12, 2017

·

3 min read

Drug Development

Immutep Limited: Operational Update

Immutep is pleased to advise that clinical studies of eftilagimod alpha are progressing well.

December 12, 2017

·

3 min read

BioMidwest

Myriad’s BRACAnalysis CDx Test Effectively Identified Metastatic Breast Cancer Patients With Improved Outcomes From Pfizer’s PARP Inhibitor, Talazoparib

Myriad’s BRACAnalysis CDx test successfully identified patients with metastatic breast cancer (MBC) who responded to Pfizer’s investigational PARP inhibitor, talazoparib.

December 12, 2017

·

7 min read

FDA Sticks Breakthrough Tag on GlaxoSmithKline's B

FDA

GlaxoSmithKline’s Nucala Wins FDA Approval for EGPA

The approval for EGPA is based on results from the pivotal, 52-week, Phase III MIRRA1 study, conducted as a collaboration between GSK and the NIAID, part of the US NIH.

December 12, 2017

·

9 min read

Business

P. (Laxmin) Laxminarain Appointed to Microbot Medical’s Board of Directors

Mr. Laxminarain first joined Johnson & Johnson in 1986 where he held roles of increasing responsibility, including President of Codman Neurosurgery from 2006 to 2017.

December 12, 2017

·

4 min read

Business

Emergent BioSolutions Awarded Department of National Defence Contract to Supply Anthrasil to the Canadian Government

This contract award follows the recent approval of Anthrasil by Health Canada under the Extraordinary Use New Drug (EUND) Regulations.

December 12, 2017

·

3 min read

JPK Reports on How Researchers at the Free University of Berlin are Using the NanoWizard ULTRA Speed AFM to Study Carbon-Based Nanoparticles (From Graphene Sheets).

PK Instruments reports on the research of the Eigler Group in the Institute for Chemistry & Biochemistry at the Free University of Berlin.

December 12, 2017

·

2 min read

Drug Development

Cyclacel Announces Presentation of Results From Phase III Seamless Study at ASH Annual Meeting

The study enrolled elderly patients with newly diagnosed AML and compared alternating cycles of decitabine and sapacitabine versus decitabine.

December 12, 2017

·

7 min read

Business

Proximagen Enhances Medicinal Chemists’ Toolkit With Flare for Structure-Based Design

Cresset is pleased to announce that Proximagen, a drug discovery and development company, has licensed Flare.

December 12, 2017

·

1 min read